For the first time in LSU Health Shreveport’s history, one of our own postdoctoral fellows, Nilesh Pandey, PhD, has secured an NIH K99 award.

David Gross, PhD, was awarded a five-year, $2.5+ million R35 grant from the NIH National Institute of General Medical Sciences.

Cory Coehoorn, PhD was awarded a one-year $210,022 grant from the LSU System Collaboration in Action Program (CAP) 2026 for the project, “Validating Machine Learning Models for Predicting Core Temperature and Heat Illness Risk in Louisiana High School Football Athletes.”

Monica Gestal, PhD, Assistant Professor of Microbiology and Immunology, was awarded a five-year $2.57 million R01 grant from the NIH National Institute of Allergy and Infectious Diseases (NIAID).

Sadiya Parveen Nesson, PhD, Assistant Professor of Microbiology and Immunology, was awarded a three-year, $766,500 COBRE grant from the Center for Lung Biology and Disease (CLBD) at LSU Baton Rouge.

Gengyi Zou, MD, PhD selected as a recipient of the Gilead Sciences Research Scholars Program Award in Solid Tumors, a highly competitive award that supports outstanding junior faculty conducting innovative cancer research.

Yoshikazu Tsukasaki, PhD was awarded a three-year, $1.1 million R01 transfer grant from the NIH National Institute of Allergy and Infectious Diseases for the remaining three years of his project.

Tousif Sultan, PHD, Assistant Professor of Cellular Biology and Anatomy, was awarded a competitive one-year grant from the AHA to investigate cell-specific pathways driving cardiac inflammation.

LSU Health Shreveport researcher Hyung Wook Nam, PhD, received a $1,609,645 NIH R01 award from the NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA) to advance research on alcohol use disorder.

LSU Health Shreveport researcher Xiaohong Lu, PhD, received a $2,312,012 NIH R01 award from the NIH National Institute of Neurological Disorders and Stroke to advance research on neurodegenerative disease and dementia.

LSUHS researchers A. Wayne Orr, PhD, and Arif Yurdagul, PhD, received a $2,869,114 NIH R01 award from the NIH National Heart, Lung, and Blood Institute (NHLBI) to advance research in cardiovascular disease.

LSU Health Shreveport researchers Oren Rom, PhD, RD, and Arif Yurdagul, PhD, received a $2,902,365 award from the NIH National Heart, Lung, And Blood Institute (NHLBI) to advance research in cardiovascular disease.

Hongyan Guo, PhD, Assistant Professor of Microbiology and Immunology, was awarded a five-year award for $3.2 million from the NIH NIAID.

Xiangqin He, PhD, Assistant Professor of Pathology and Translational Pathobiology, was awarded a three-year R00 grant from the NIH National Heart, Lung, and Blood Institute totaling $744,942.

Deepak Kumbhare, PhD, Assistant Professor of Neurosurgery, who was recently awarded a $150,000 New Investigator Grant from the Heffter Research Institute.

For the first time in LSU Health Shreveport’s history, one of our own postdoctoral fellows, Nilesh Pandey, PhD, has secured an NIH K99 award.

In addition to being the second leading cause of death worldwide, strokes often create life-altering challenges for survivors. Dr. Xuemei Zong sees an urgent need for safer and more effective strategies that can support brain recovery after stroke.

Biz Magazine - The competitive grant renews the center’s funding following its initial five-year award in 2021 and will support continued research into immunology, faculty development and biomedical research infrastructure. The research focuses on advancing treatments for drug-resistant viruses and bacteria as well as therapies for cancer and cardiovascular disease.

David Gross, PhD, was awarded a five-year, $2.5+ million R35 grant from the NIH National Institute of General Medical Sciences.

A team of researchers at LSU Health Shreveport have taken an important step toward making a widely used lung cancer treatment safer for patients.

Amr Salem, DVM, PhD, studies how changes in certain genes can affect blood vessels and lead to cardiovascular disease. At the forefront of Dr. Salem’s work is the use of gene-editing technologies CRISPR and prime editing (PE).

The Advocate - Some of those studies have produced “a really remarkable effect,” said Kevin Murnane, a professor of pharmacology, toxicology and neuroscience and a professor of psychiatry and behavioral medicine at LSU Health-Shreveport.

KTBS - Wastewater in Caddo Parish contains some of the highest levels of methamphetamine in the world, according to new research from LSU Health Shreveport.

Monica Gestal, PhD, Assistant Professor of Microbiology and Immunology, was awarded a five-year $2.57 million R01 grant from the NIH National Institute of Allergy and Infectious Diseases (NIAID).